Basically, what you’re saying is that artificial intelligence can actually contribute to global efforts to address many chronic and degenerative diseases, but the problem is not so much the speed of progress as letting strictly profit-driven companies commercialize products that are not yet fit for purpose.
However, I think artificial intelligence has potential to drive major breakthroughs in ultra-specialized treatments. In your research or across the overall artificial intelligence market, have you come across opportunities for more specialized treatments that are tailored to each individual rather than relying on more general approaches?